MDS Virtual Congress 2020

September 12-16, 2020. Virtual Congress. www.mdscongress.org

View by Title View Categories

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

An Analysis of Health Care Utilization in Functional Movement Disorders: Does Diagnosis Make a Difference?

K. Kyle, A. Wu, F. Agosta (Los Angeles, CA, USA)
An Analysis of Parkinson’s Disease Medication Treatment Patterns among Medicaid Patients

M. Johnsrud, K. Richards, R. Sasane, M. Leoni, S. Arcona (Austin, TX, USA)
An Apparent Cluster of Parkinson’s Disease (PD) in a Golf Community

J. Nutt, A. Zajack, J. Sandsness, V. Palmer, C. Meng, C. Tanner, P. Spencer (Portland, OR, USA)
An introduction to the Global Parkinson’s Genetics Program (GP2)

C. Blauwendraat, E. Riley, A. Singleton (Bethesda, MD, USA)
An investigation of the relationships between measures of pain, physical activity levels, sleep quality and mood in people with Parkinson’s disease

V. Nguy, B. Barry, N. Moloney, L. Hassett, C. Canning, S. Lewis, N. Allen (Sydney, Australia)
An objective comparison of forward and backward postural instability in early Parkinson’s disease

C. Lu, S. Amundsen Huffmaster, K. Louie, R. McGovern, C. MacKinnon, S. Cooper, R. Lowe, J. Vitek, R. Abulu (Minneapolis, MN, USA)
An Objective Tool to Guide Target Selection for DBS in PD (GPi vs STN)- integration into Thomas Jefferson’s multidisciplinary Movement Disorders Center, an Update

R. Burke, L. Meytin, D. Kremens, J. Ratliff, A. Sharan, C. Wu, T. Liang (Philadelphia, PA, USA)
An Observational Study for the Application of Wearable, Multi-Sensor Technology to Characterize Motor Function of Parkinson’s Disease Patients in Japan (SWJ-001): An Innovative Protocol

G. Oyama, T. Hatano, W.J Marks, R. Kapur, J. Fernandez, K. Fujikawa, T. Ogawa, H. Kamo, Y. Oji, H. Takeshige-Amano, D. Taniguchi, R. Nakamura, F. Sasaki, S. Ueno, N. Hattori (Tokyo, Japan)
An Observational Study for the Application of Wearable, Multi-Sensor Technology to Characterize Motor Function of Parkinson’s disease Patients in Japan (SWJ-001): Device Adherence

T. Hatano, G. Oyama, J. Fernandez, K. Fujikawa, W.J Marks, R. Kapur, T. Ogawa, H. Kamo, Y. Oji, H. Takeshige-Amano, D. Taniguchi, R. Nakamura, F. Sasaki, S. Ueno, N. Hattori (Tokyo, Japan)
An Open-Label, Phase 1b Study of the Neuroactive Steroid GABAA Receptor Positive Allosteric Modulator SAGE-324 in Essential Tremor

H. Colquhoun, D. Nguyen, M. Qin, A. Wehr, J. Doherty, S. Kanes (Cambridge, MA, USA)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z